Type 1 Gaucher disease: Phenotypic expression and natural history in Japanese patients

Blood Cells, Molecules and Diseases

Volumn 24, Issue 1, 1998, Pages 73-81

  Ida, Hiroyuki ^a   Rennert, Owen M ^b   Ito, Takeru ^a   Maekawa, Kihei ^a   Eto, Yoshikatsu ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Children's Medical Center   (United States)

Author keywords

Gaucher disease; Natural history; Phenotype

Indexed keywords

CLINICAL ARTICLE; ENZYME DEFICIENCY; GAUCHER DISEASE; GROWTH RETARDATION; HEPATOSPLENOMEGALY; HUMAN; JAPAN; PRIORITY JOURNAL; REVIEW;

EID: 0031899307     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1006/bcmd.1998.0172     Document Type: Article

References (17)

1. Brady R O, Murray G J, Barton N W. Modifying exogenous glucocerebrosidase for effective replacement therapy in Gaucher disease. J Inher Metab Dis. 17:1994;510-519.
2. Hobbs J R, Jones K H, Shaw P J, Lindsay I, Hancock M. Beneficial effect of pretransplant splenectomy on displacement bone marrow transplantation for Gaucher's syndrome. Lancet. I:1987;1111-1115.
3. Ida H, Iwasawa K, Kawame H, Rennert O M, Maekawa K, Eto Y. Characteristics of gene mutations among 32 unrelated Japanese Gaucher disease patients: absence of the common Jewish 84GG and 1226G mutations. Hum Genet. 95:1995;717-720.
4. Ida H, Rennert O M, Kawame H, Maekawa K, Eto Y. Mutation prevalence among 47 unrelated Japanese patients with Gaucher disease: identification of four novel mutations. J Inher Metab Dis. 20:1997;67-73.
5. Patterson M C, Horowitz M, Abel R B. Isolated horizontal supranuclear gaze palsy as a marker of severe systemic involvement in Gaucher disease. Neurology. 43:1993;1993-1997.
6. Ida H, Rennert O M, Ito T, Maekawa K, Eto Y. Clinical and genetic studies of five fatal cases of Japanese Gaucher disease type 1. Acta Paediatr Jpn. 38:1996;233-236.
7. Zevin S, Abrahamov A, Hadas-Halpern I. Adult-type Gaucher disease in children: genetic, clinical features and enzyme replacement therapy. QJM. 86:1993;565-573.
8. Zimran A, Kay A, Saven A, Thurston D, Garver P, Beutler E. Gaucher disease: clinical, laboratory, radiologic and genetic features in 53 patients. Medicine. 71:1992;337-353.
9. Zimran A, Sorge J, Gross E, Kubitz M, West C, Beutler E. Prediction of severity of Gaucher's disease by identification of mutations at DNA level. Lancet. 2:1989;349-352.
10. Sibille A, Eng C M, Kim S J, Pastores G, Grabowski G A. Phenotype/genotype correlations in Gaucher disease type 1: clinical and therapeutic implications. Am J Hum Genet. 52:1993;1094-1101.
11. Barton N W, Brady R O, Dambrosia J M. Replacement therapy for inherited enzyme deficiency - macrophage-targeted glucocerebrosidase for Gaucher's disease. N Engl J Med. 324:1991;1464-1470.
12. Grabowski G A, Barton N W, Pastores G. Enzyme therapy in type 1 Gaucher disease: comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sources. Ann Int Med. 122:1995;33-39.
13. Kaplan P, Mazur A, Manor O. Acceleration of retarded growth in children with Gaucher disease in children with Gaucher disease after treatment with alglucerase. J Pediatr. 129:1996;149-153.
14. Rosenthal D I, Doppelt S H, Mankin H J. Enzyme replacement therapy for Gaucher disease: skeletal responses to macrophage-targeted glucocerebrosidase. Pediatrics. 96:1996;629-637.
15. Ringdén O, Groth C G, Erikson A, Granqvist S, Månson J E, Sparrelid E. Ten years' experience of bone marrow transplantation for Gaucher disease. Transplantation. 59:1995;864-870.
16. Duursma S A, Aerts J MFG, Belmatoug N. Management of Gaucher disease. Current status and future directions. A roundtable discussion. Seminars in Hematology. 32:1995;45-52.
17. Beutler E, Grabowski G A. Gaucher disease. Scriver C R, Beaudet A L, Sly W S, Valle P. The Metabolic and Molecular Bases of Inherited Disease. 1995;2641-2670 McGraw-Hill Book Co. New York.